View CMS HAI Reporting Requirements to NHSN
Status of APIC comments on proposed infection prevention and control regulations.
Proposed Regulation* |
Impact on Infection Prevention |
Committee Action and Status |
Which of APIC Strategic Goals does this related to? |
CDC: Request for Information on water management programs |
CDC is seeking information of effective methods for achieving implementation of water management programs (WMPs) intended to reduce Legionella growth and transmission in buildings at inceased risk. APIC response to PACCARB Request for Information — January 7, 2019 Joint APIC/SHEA letter to PACCARB — February 15, 2019 |
APIC members are encouraged to provide information on behalf of their facilities Deadline: 10/17/17 |
|
CMS: CY 2018 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems proposed rule | Updates infection-related provisions in the Hospital Outpatient Quality Reporting Program and the Ambulatory Surgical Canter Quality Reporting Program |
|
|
CMS: CY 2018 End-Stage Renal Disease Prospective Payment System annual update proposed rule | Updates infection-related provisions in the ESRD Quality Incentive Program (QIP). |
|
|
CMS: FY 2018 Hospital Inpatient Prospective Payment System and Long-Term Care Payment System annual update | Updates HAI measures and infection-related provisions for acute care hospitals, long-term acute care hospitals, PPS-exempt cancer hospitals, and inpatient psychiatric facilities. |
|
|
FDA: Coordinated development of antimicrobial drugs and antimicrobial susceptibility test devices, draft guidance | Draft guidance for industry on coordination in development of antimicrobial drugs and antimicrobial susceptibility test devices. | Comments submitted 11/18/16 |
|
HHS: Update of Quarantine Regulations for Control of Communicable Diseases | Amends domestic and foreign quarantine regulations to protect public health. |
|
|
CMS: CY 2017 End-Stage Renal Disease Prospective Payment System proposed rule | Updates infection prevention measures in the End-Stage Renal Disease Prospective Payment System. |
|
|
CMS: CY 2017 Home Health Prospective Payment System proposed rule | Updates infection prevention measures in the Home Health Prospective Payment System. |
|
|
CMS: CY 2017 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems (OPPS/ASC) proposed rule | Updates infection prevention measures in the Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center payment system. |
|
|
CMS: Hospital and Critical Access Hospital Changes to Promote Innovation, Flexibility, and Improvement in Patient Care proposed rule | Updates Medicare Conditions of Participation (CoPs) for hospitals and crical access hospitals related to infection prevention and antibiotic prescribing. | Comments submitted 8/15/16 |
|
CMS: Merit-Based Incentive Payment System (MIPS) under the Physician Fee Schedule, proposed rule | Creates a new program to determine Medicare payment for physicians based on quality rather than volume of care |
|
|
CMS: FY 2017 Skilled Nursing Facilities Prospective Payment System, Value-Based Purchasing and Quality Reporting programs proposed rule | Updates infection prevention measures in the Skilled Nursing Facilities Quality Reporting and Value-Based Purchasing programs. |
|
|
CMS: FY 2017 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Payment System (IPPS/LTCH) proposed rule | Updates HAI measures and infection-related provisions for acute care hospitals, long-term acute care hospitals, PPS-exempt cancer hospitals, and inpatient psychiatric facilities. |
|
|
CMS: FY 2017 Inpatient Rehabilitation Facility Prospective Payment System | Updates HAI measures in the Inpatient Rehabilitation Facility Quality Reporting Program |
|
|
FDA: Ban on powdered gloves | Proposal to ban powdered surgeon’s gloves, powdered patient examination gloves, and absorbable powder for lubricating a surgeon’s glove. |
|
|
FDA: Donor screeing recommendations to reduce Zika transmissions | Guidance for industry on donor screening recommendations to reduce the risk of transmission of Zika virus by human cells, tissues, and cellular and tissue-based products – released for immediate implementation. | Comments submitted 3/25/16 |
|
FDA: Medical device reprocessing | Request for comments concerning the service, maintenance, refurbishment, and alteration of medical devices, including endoscopes, by third-party entities and original equipment manufacturers. | Comments submitted 5/9/16 |
|
FDA: Reclassification of blood lancets | Proposal to reclassify single use and single patient blood lancets from class I (requiring general controls) to class II (requiring special controls) | Comments submitted 5/24/16 |
|
OSHA: PPE information collection request | Requests extension of current information collection requirements in the Personal Protective Equipment section of the OSHA General Industry Standard. | Comments submitted 4/18/16 |
|
FDA: Fecal Transplantation | Draft guidance for industry on enforcement of policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. | Comments submitted 4/1/16 |
|
CDC/NIOSH: Monitoring and Coordinating PPE in Healthcare to Enhance Domestic Preparedness for Ebola Response | Proposal to develop an ongoing hospital surveillance system to evaluate and monitor PPE usage and effectiveness in healthcare workers including Ebola protection. | Comments submitted 3/18/16 |
|
All federal agencies: Revisions to the Common Rule, proposed rule | Updates the Federal Policy for the Protection of Human Research Subjects, including quality assurance, quality improvement, and public health surveillance activities. |
|
|
CMS: Revisions to Discharge Planning Requirements for Hospitals, Critical Access Hospitals and Home Health Agencies proposed rule | Updates discharge planning requirement for Medicare and Medicaid participation to comply with the “Improving Medicare Post-Acute Care Transformation Act of 2014” (IMPACT Act). | Comments submitted 12/28/15 |
|
AHRQ: Draft Technical Brief | Critical analysis of evidence for resident safety practices in nursing home settings. | Comments submitted 11/20/15 |
|
Selection of the appropriate package type terms and recommendations for labeling injectable medical products packaged in multiple-dose, single-dose, and single-patient-use containers for human use. | Comments submitted 12/17/15 |
|
|
Recommendations from NQF Patient Safety Standing Committee on endorsement or revision of measures, including infection-related measures. | Comments submitted 9/3/15 |
|
|
Premarket regulatory requirements and performance testing needed to support liquid barrier claims for gowns intended for use in healthcare settings. | Comments submitted 8/28/15 |
|
|
Updates requirements for Long-Term Care Facility participation in Medicare, including infection control provisions |
|
||
CMS: CY 2016 Physician Fee Schedule proposed rule | Updates infection-related measures in the Physican Quality Reporting System for Medicare payment determination. |
|
|
CMS: CY 2016 Home Health Prospective Payment System proposed rule | Updates infection-related Home Health Quality Reporting requirements for Medicare payment determination. |
|
|
CMS: CY 2016 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center (OPPS/ASC) Payment System proposed rule | Updates infection-related measures to the Hospital Outpatient Qualitry Reporting Program and ASC Quality Reporting Program for Medicare payment determination. |
|
|
CMS: CY 2016 End-Stage Renal Disease Prospective Payment System proposed rule | Updates infection-related measures to the ESRD Quality Incentives Program for Medicare payment determination. |
|
|
FDA: Healthcare Antiseptics proposed rule | Request for additional data from manufacturers on safety and effectiveness of healthcare antiseptic products. | Comments submitted 10/26/15 |
|
NQF: Data for Systematic Improvement: Summarizing an NQF Meeting on the Data Needed for Sustainably Improving Healthcare | Recommendations from NQF meeting of stakeholders to identify opportunities to improve data and make it more useful for systematic improvement. | Comments submitted 6/15/15 |
|
CMS: FY 2016 Hospital Inpatient Prospective Payment System (IPPS/LTCH) Update | Updates HAI measures in Hospital Inpatient Quality Reporting, Hospital Value-Based Purchasing, HAC Reduction Program, LTCH Quality Reporting programs for Medicare payment determination. |
|
|
CMS: FY 2016 Inpatient Rehabilitation Facility (IRF) Prospective Payment System update | Updates the HAI measures in the IRF Quality Reporting Program for Medicare payment determination. |
|
|
CMS: Meaningful Use Stage 3 | The Stage 3 proposed rule streamlines the program by reducing the number of clinical quality measures and aligning EHR measures with measures in other CMS quality reporting programs. |
|
|
HHS: Health IT Certification Criteria | Updates and modifies health information technology certification criteria |
|
|
FDA: Reprocessing of Duodenoscopes | Request for comments on reprocessing of duodenoscopes and other endoscopes to the Gastroenterology and Urology Devices Panel of the FDA Medical Devices Advisory Committee | Comments submitted 4/29/15 |
|
FDA: Draft Guidance for Industry | Mitigating cross-contamination risk from irrigation accessories for flexible gastrointestinal endoscopes | Comments submitted 4/16/15 |
|
CMS: Medicare Conditions for Coverage (CfCs) for End-Stage Renal Disease (ESRD) facilities | APIC sent CMS suggestions for possible revisions to CfCs for ESRD facilities that would incorporate evidence-based infection prevention practice standards into the CfCs. | Comments submitted 4/1/2015 |
|
HHS: Ethical considerations of Ebola Emergency Response | Request for Comments on the ethical considerations and implications of public health emergency response with a focus on the Ebola epidemic. |
|
|
HHS: Federal Health IT Strategic Plan 2015-2020 | Strategic plan to expand widespread adoption of health IT and increase interoperability among users to improve healthcare. |
|
*Federal Agency Abbreviations:
CDC: Centers for Disease Control and Prevention
CMS: Centers for Medicare and Medicaid Services
HICPAC: Healthcare Infection Control Practices Advisory Committee
NIOSH: National Institute for Occupational Safety and Health
OSHA: Occupational Safety and Health Administration
FDA: Food and Drug Administration
NQF: National Quality Forum
To access APIC comments organized by agency, click on the appropriate agency page.
- U.S. Agency for Healthcare Research and Quality (AHRQ)
- U.S. Centers for Disease Control and Prevention (CDC)
- U.S. Centers for Medicare & Medicaid Services (CMS)
- U.S. Environmental Protection Agency (EPA)
- U.S. Food and Drug Administration (FDA)
- U.S. Government Accountability Office (GAO)
- U.S. Department of Health and Human Services (HHS)
- U.S. Occupational Safety and Health Administration (OSHA)
- National Quality Forum (NQF)
- U.S. Department of Agriculture (USDA)
U.S. government health agencies
View information about federal agencies with jurisdiction over infection prevention and control.